ChemSpider 2D Image | Bendamustine Hydrochloride | C16H22Cl3N3O2

Bendamustine Hydrochloride

  • Molecular FormulaC16H22Cl3N3O2
  • Average mass394.724 Da
  • Monoisotopic mass393.077759 Da
  • ChemSpider ID69528

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, hydrochloride (1:1) [ACD/Index Name]
1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, monohydrochloride
3543-75-7 [RN]
4-{5-[Bis(2-chlorethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butansäurehydrochlorid [German]
4-{5-[Bis(2-chlorethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butansäurehydrochlorid (1:1) [German] [ACD/IUPAC Name]
4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride
4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride (1:1) [ACD/IUPAC Name]
5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzimidazole-2-butanoic Acid Monohydrochloride
acide 4-{5-[bis(2-chloroéthyl)amino]-1-méthyl-1H-benzimidazol-2-yl}butanoïque chlorhydrate
Acide 4-{5-[bis(2-chloroéthyl)amino]-1-méthyl-1H-benzimidazol-2-yl}butanoïque, chlorhydrate (1:1) [French] [ACD/IUPAC Name]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

981Y8SX18M [DBID]
SDX-105 [DBID]
UNII:981Y8SX18M [DBID]
CCRIS 1864 [DBID]
IMET 3393 [DBID]
NSC 138783 [DBID]
UN 2811 [DBID]
UN2811 [DBID]
UNII-981Y8SX18M [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Safety:

      H302+H312+H332 W&J PharmaChem, Inc. [203096]
      P302+P352+P304+P312+P503+P351+P338+P403+P235+P280+P260 W&J PharmaChem, Inc. [203096]

    • Target Organs:

      DNA damage TargetMol T0095

    • Bio Activity:

      Apoptosis Tocris Bioscience 3681
      Apoptosis Inducers Tocris Bioscience 3681
      Bendamustine Hcl(SDX105; EP-3101) is a DNA-damaging agent with IC50 of 50 ?M.; Target: Others; Approved: March 2008; Treatment with Bendamustine results in a 60% to 80% down-regulation of the mRNA expression of all three of these genes [polo-like kinase 1 (PLK-1), Aurora Kinase A, and cyclin B1] in SU-DHL-9 cells. MedChem Express HY-B0077
      Cell Biology Tocris Bioscience 3681
      Cytostatic agent that displays activity in non-Hodgkin's lymphomas. Exhibits bifunctionality; combines DNA alkylating properties with those of purine analogs. Tocris Bioscience 3681
      Cytostatic agent; exhibits DNA alkylating and purine analog properties Tocris Bioscience 3681
      DNA damage TargetMol T0095
      DNA Damage/DNA Repair TargetMol T0095
      Others MedChem Express HY-B0077

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement